
NEW BRITAIN, CT – Acting Public Health Commissioner Deidre Gifford got the Johnson & Johnson COVID-19 vaccine Friday at a Stop & Shop in New Britain.
Gifford said when the vaccine first came out they started hearing questions about whether it was as good as others.
“We wanted to say ‘yes’ the J&J vaccine is as good as the others,” Gifford said. “They are all excellent vaccines.”
The J&J vaccine was found to be 72% protective in the United States, 66% protective in South America, and 57% protective in South Africa.
“They’re all extremely effective and they’re all extremely safe,” Gifford said of all the COVID-19 vaccines.
Gifford who falls into the 55 and older group urged those in the 55 to 45 age bracket who could start making appointments Friday to be patient.
“The best vaccine for you is the first one you can get,” Gifford said.
Gifford got her vaccine at Stop & Shop, which will have a limited supply of vaccine and it will be administered by appointment.
There have been about 130,000 first vaccine doses available every week in Connecticut, according to Gifford. She said she expects that to increase over the next few weeks.
She said the allocation of Johnson & Johnson has been relatively flat over the past few weeks but in early April they expect to see “a big acceleration in the amount of Johnson & Johnson,” vaccine.
“Soon, as the governor has said, we anticipate some time in May that the supply is actually going to be more than the demand that we have for vaccines,” Gifford said.
She said it’s a temporary situation and sometimes there are problems with bottlenecks, but she anticipates it will work itself out.
Friday was the first day those 45 and older could sign up for a vaccine.
There are about 477,000 people in that age bracket, but Josh Geballe, the state’s chief operating officer, said around 90,000 have already been vaccinated. He estimated only about 200,000 of the newly eligible group will be hunting for one of the 130,000 first doses.
“As we get these younger age groups, we’re able to do it faster, we’re getting a lot more vaccines, and also it does appear that there might be a slightly lower take-rate as well,” Gov. Ned Lamont said Thursday at his biweekly press briefing.
Support authentic, locally owned and operated public service journalism!
Nearly 1 million people have received at least the first shot of the Pfizer-BioNTech and Moderna vaccines. And about half of those have receive their second dose, while about 36,208 Connecticut residents have received the Johnson & Johnson vaccine.
That means about 62% of those 55 and older have received at least one dose and 33% of the state’s total population has been vaccinated.
“We are going to have plenty of vaccines over the course of the next month,” Lamont said.
More Health Care News & Analysis

AG’s Tackle Mental Health Parity
Attorneys General in Connecticut and Rhode Island threw their support Monday behind a coalition of mental health advocacy groups asking a federal appeals court to revisit a recent ruling giving insurance companies more flexibility to deny mental health claims. In late March, a three-judge panel in the California-based 9th U.S. Court of Appeals reversed a…
Keep reading
Budget Green Lights Psychedelic Therapies
Buried in the budget Gov. Ned Lamont signed this week is a provision that would create a pilot program to allow Connecticut to be the first-in-the-nation to study the impact of psychedelic drugs like psilocybin and MDMA on patients with depression and PTSD. The budget now creates a pilot program within the Department of Mental…
Keep reading
Officials Highlight Effort To Boost Mental Health Services For Kids
At a Hartford-based community provider Wednesday, Gov. Ned Lamont and a handful of his agency commissioners highlighted the expected impact of more than $100 million in recently passed funding aimed at increasing behavioral health services for Connecticut children. The governor appeared at The Village for Families and Children, a recipient of new state funding included…
Keep reading
Democrats Turn Focus To Roe v. Wade
With the legislative session and the conventions in the rearview mirror, Democrats in Connecticut are turning their focus to the U.S. Senate and the upcoming vote to codify Roe v. Wade and the impact it could have on the 2022 Elections. U.S. Sen. Chris Murphy was on Fox News Sunday talking about the issue, which…
Keep reading
OP-ED | Policymakers Did Little to Lower Healthcare Costs This Session
Last year, Connecticut policymakers accomplished little to reduce the cost of healthcare, and those costs haven’t gotten any better since then. Incumbents will be asked what they did this year to provide some relief. Unfortunately, they have little to offer.
Keep reading
ANALYSIS | Will the 2022 Legislative Session Help or Hurt Democrats in the Fall?
The short but surprisingly productive 2022 session of the General Assembly is coming to a close this week. As Democrats race to pass bills, and Republicans do all they can to talk them to death, a question that has to be on the minds of a lot of legislators is what the session means, if…
Keep reading